Data Year:

For its 2025 fiscal year, ZOETIS INC, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Biotechnology industry
Kristin C. Peck
Chief Executive Officer
Total Compensation $19,046,509 View details Pay Rank By Title In Biotechnology industry #36 View more
Wetteny Joseph
Executive Vice President ("EVP") and Chief Financial Officer
Total Compensation $5,596,513 View details Pay Rank By Title In Biotechnology industry #47 View more
Robert J. Polzer
Former EVP and President of Research and Development
Total Compensation $3,667,157 View details Pay Rank By Title In Biotechnology industry #69 View more
Roxanne Lagano
EVP, General Counsel and Corporate Secretary
Total Compensation $2,825,280 View details Pay Rank By Title In Biotechnology industry #36 View more
Jamie Brannan
EVP and Chief Commercial Officer
Total Compensation $3,974,341 View details Pay Rank By Title In Biotechnology industry #61 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at ZOETIS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. ZOETIS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. ZOETIS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Kristin C. Peck
Chief Executive Officer
Total Cash $3,537,000 Equity $13,624,812 Other $1,884,697 $19,046,509
Wetteny Joseph
Executive Vice President ("EVP") and Chief Financial Officer
Total Cash $1,632,000 Equity $3,799,572 Other $164,941 $5,596,513
Robert J. Polzer
Former EVP and President of Research and Development
Total Cash $1,300,720 Equity $2,221,716 Other $144,721 $3,667,157
Roxanne Lagano
EVP, General Counsel and Corporate Secretary
Total Cash $1,304,800 Equity $1,389,693 Other $130,787 $2,825,280
Jamie Brannan
EVP and Chief Commercial Officer
Total Cash $1,393,920 Equity $2,231,893 Other $348,528 $3,974,341
For its 2025 fiscal year, ZOETIS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Kristin C. Peck CEO Pay $19,046,509 Median Employee Pay $80,592 CEO Pay Ratio 236:1
For its 2025 fiscal year, ZOETIS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Antoinette R. Leatherberry Total Cash $355,000
Frank A. D'Amelio Total Cash $375,000
Gavin D.K. Hattersley Total Cash $356,250
Gregory Norden Total Cash $375,000
Louise M. Parent Total Cash $373,750
Mark Stetter Total Cash $316,667
Michael B. McCallister Total Cash $500,000
Paul M. Bisaro Total Cash $350,000
Robert W. Scully Total Cash $300,000
Sanjay Khosla Total Cash $350,000
Stephanie Tilenius Total Cash $258,333
Vanessa Broadhurst Total Cash $355,000
Willie M. Reed Total Cash $375,000
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.